Treatment of human prostate tumors PC-3 and TSU-PR1 with standard and investigational agents in SCID mice

Investigational New Drugs

Volumn 15, Issue 2, 1997, Pages 99-108

  Polin, Lisa ^a   Valeriote, Frederick ^a   White, Kathryn ^a   Panchapor, Chiab ^a   Pugh, Susan ^a   Knight, Juiwanna ^a   LoRusso, Patricia ^a   Hussain, Maha ^a   Liversidge, Elaine ^b   Peltier, Nancy ^b   Golakoti, Trimurtulu ^c   Patterson, Gregory ^c   Moore, Richard ^c   Corbett, Thomas H ^a,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Nanosystems LLC   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

Chemotherapy; PC 3; Preclinical; Prostate tumors; TSU PR1

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; PACLITAXEL; VINBLASTINE SULFATE;

ADULT; AGED; ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CASE REPORT; CONTROLLED STUDY; EXPERIMENTAL NEOPLASM; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE TUMOR; TUMOR MODEL; TUMOR VOLUME;

AGED; ANIMALS; ANTINEOPLASTIC AGENTS; DEPSIPEPTIDES; DRUGS, INVESTIGATIONAL; FEMALE; HUMANS; LACTAMS; LACTONES; MALE; MICE; MICE, NUDE; MICE, SCID; MIDDLE AGED; PACLITAXEL; PIPERAZINES; PROSTATIC NEOPLASMS; VINBLASTINE;

EID: 8244245753     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005856605726     Document Type: Article

References (15)

1. Corbett T, Valeriote F, Baker L: Is the P388 murine tumor no longer adequate as a drug discovery model? Invest New Drugs 5:3-20, 1987
2. Polin L, Jones J, LoRusso P, Baker L, Valeriote F, Corbett, TH: Evaluation of Chemotherapeutic Agents in the SCID Mouse. AACR 36:303, 1995
3. Polin L, Jones J, LoRusso P, Baker L, Valeriote F, Corbett TH: The SCID mouse: A better model for human tumor xenografts. AACR 36:303, 1995
4. Corbett T, Valeriote F, LoRusso P, et al.: Tumor models and the discovery and secondary evaluation of solid tumor active agents. Int J Pharmacogn, Supp 33:102-122, 1995
5. Kaighn ME, Lechner JF, Babcock MS, et al.: The Pasadena Cell Lines. In: Models for Prostate Cancer, Alan R Liss (ed). Inc 150 5th Ave, NY, pp 85-109, 1980
6. Ilzumi T, Yazaki T, Kanoh S, et al.: Establishment of a New Prostatic Carcinoma Cell Line (TSU-PR1). J Urol 137:1304-1306, 1987
7. Corbett TH, Roberts BJ, Trader MW, Laster WR Jr, Griswold DP Jr, Schabel FM Jr: Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. Cancer Treat Rep 66(5): 1187-1200, 1982
8. Corbett TH, Leopold WR, Dykes DJ, Roberts BJ, Griswold DP Jr, Schabel FM Jr: Toxicity and anticancer activity of a new triazine antifolate (NSC-127755). Cancer Res 42:1707-1715, 1982
9. Corbett TH, Valeriote FA: Rodent Models in Experimental Chemotherapy, The Use of Rodent Tumors in Experimental Cancer Therapy: Conclusions and Recommendations, RF Kallman (ed) Pergamon Press, Chapt 50, pp 233-247, 1987
10. Corbett TH, Bissery M-C, LoRusso P-M, Polin L: 5-Fluorouracil containing combinations in murine tumor systems. Invest New Drugs 7:37-49, 1989
11. Corbett TH, Valeriote FA, Polin L, et al.: Discovery of solidtumor active agents using a soft-agar-colony-formation disk-diffusion-assay. Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development. FA Valeriote, TH-Corbett and LH Baker (eds) Kluwer Academic Publishers, pp. 33-87, Boston/Dordrecht, London, 1992
12. Carter CA, Dykes DJ: Characterization of tumor growth and drag sensitivity for human prostate tumors implanted orthotopically. Proc Am Assoc Cancer Res 35:280, 1994
13. Corbett TH, Valeriote FA, Demchik L, Polin L, Panchapor C, Pugh S, White K, Kushner J, Jones J, Jones L, Foster B, Wiegand R, Lisow L, Golakoti T, Heltzel C, Ogino J, Patterson G, Moore R: Preclinical anticancer activity of Cryptophycin-8. J Exp Ther Oncol 2:1996
14. Roth BJ, Yeap BY, Wilding G, Kasimis B, McLeod D, Loehrer PJ: Taxol in advanced, hormone-refractory carcinoma of the prostate cancer 72:2457-2460, 1993
15. Dykes DJ, Abbott BJ, Mayo JG, Harrison SD Jr, Laster WR Jr, Simpson-Herren L, Griswold DP Jr: Development of human tumor xenograft models for in vivo evaluation of new antitumor drags. Contrib Oncol Basel, Karger, Vol 42, pp 1-22, 1992